Details for New Drug Application (NDA): 062590
✉ Email this page to a colleague
NDA 062590 describes KEFUROX IN PLASTIC CONTAINER, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the KEFUROX IN PLASTIC CONTAINER profile page.
The generic ingredient in KEFUROX IN PLASTIC CONTAINER is cefuroxime sodium. There are sixty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.
The generic ingredient in KEFUROX IN PLASTIC CONTAINER is cefuroxime sodium. There are sixty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.
Summary for 062590
| Tradename: | KEFUROX IN PLASTIC CONTAINER |
| Applicant: | Lilly |
| Ingredient: | cefuroxime sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS | Strength | EQ 750MG BASE/VIAL | ||||
| Approval Date: | Jan 10, 1986 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1.5GM BASE/VIAL | ||||
| Approval Date: | Jan 10, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
